Thousands of individuals in England with type 1 diabetes are set to receive access to a groundbreaking technology known as artificial pancreas.
diabetes
Biotech Company Fractyl Health is testing a gene therapy which won’t require daily or multiple injections for Type 2 Diabetes. The concept behind this hoped-for breakthrough is to replicate the current treatments Ozempic and Wegovy, but as a once-off jab which will last for years. The aim is to lower blood sugar and weight like […]